Table 3 Joinpoint Regression Results Post-CEDAW Ratification
Health Indicator | Mean | Trend 1 | Trend 2 | Trend 3 | Trend 4 | AAPC (95% CI) | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Ratification Year | 20 Years Post-Ratification | Year | APC (95% CI) | Year | APC (95% CI) | Year | APC (95% CI) | Year | APC (95% CI) | Overall (0–20 Years) | |
Low Income Countries | |||||||||||
Female Mortality Rate | 307.01 | 281.51 | 0–3 | 0.1 (−0.3, 0.6) | 3–11 | 0.5 (0.4, 0.6) | 11–15 | -0.6 (−1.1, −0.2) | 15–20 | −2.2 (−2.3, −2.0) | −0.5 (−0.6, −0.3) |
Female Life Expectancy | 53.78 | 59.11 | 0–4 | 0.4 (0.3, 0.6) | 4–13 | 0.1 (0.1, 0.2) | 13–20 | 1.0 (0.9, 1.0) | – | – | 0.5 (0.4, 0.5) |
Middle Income Countries | |||||||||||
Female Mortality Rate | 202.18 | 169.57 | 0–10 | −0.2 (−0.2, − 0.1) | 10–18 | −1.2 (− 1.3, − 1.0) | 18–20 | −3.9 (−5.5, − 2.4) | – | – | −0.9 (− 1.1, − 0.8) |
Female Life Expectancy | 65.00 | 69.91 | 0–12 | 0.3 (0.3, 0.3) | 12–20 | 0.4 (0.4–0.5) | – | – | – | – | 0.4 (0.3, 0.4) |
High Income Countries | |||||||||||
Female Mortality Rate | 97.84 | 77.06 | 0–7 | −1.6 (− 1.9, − 1.4) | 7–13 | −0.7 (− 1.1, − 0.3) | 13–17 | − 2.0 (− 3.0, − 1.0) | 17–20 | − 0.1 (− 1.2, 1.0) | −1.2 (− 1.5, − 0.9) |
Female Life Expectancy | 76.08 | 79.96 | 0–7 | 0.3 (0.3, 0.3) | 7–12 | 0.1 (0.1, 0.2) | 12–15 | 0.4 (0.1, 0.7) | 15–20 | 0.2 (0.2, 0.3) | 0.2 (0.2, 0.3) |